Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin (original) (raw)

Plasma Phenytoin Levels Produced by Various Phenytoin Preparations

Lloyd Sansom

Medical Journal of Australia, 1975

View PDFchevron_right

Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs

laura Montoya

Journal of Veterinary Pharmacology and Therapeutics, 2008

View PDFchevron_right

Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit

Marco Poloni

European Journal of Drug Metabolism and Pharmacokinetics, 2002

View PDFchevron_right

Different pharmacokinetic parameters of phenytoin in Iranian Outpatients: Need to Optimize the current Dosage administration

Ebrahim Salehifar

Iranian Journal of …, 2010

View PDFchevron_right

The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone

Kari Aranko

British Journal of Clinical Pharmacology, 1994

View PDFchevron_right

BIOAVAILABILITY AND DISPOSITION KINETICS OF ERYTHROMYCIN IN NORMAL AND METABOLICALLY ALTERED RABBITS FOLLOWING ORAL ADMINISTRATION

Muhammad Nawaz

View PDFchevron_right

Assessment of inter-individual variability in predicted phenytoin clearance

Matthew Doogue

European Journal of Clinical Pharmacology, 2009

View PDFchevron_right

Pharmacokinetics of erythromycin after intravenous, intramuscular and oral administration to cats

laura Montoya

Veterinary Journal, 2011

View PDFchevron_right

Effect of aceclofenac on pharmacokinetic of phenytoin

Rupa Joshi

Pakistan journal of …, 2012

View PDFchevron_right

Evaluation of phenytoin serum levels following a loading dose in the acute hospital setting

Robert A Gross

Seizure, 2017

View PDFchevron_right

Oral and intramuscular phenytoin

R Eugene Ramsay

Clinical Pharmacology & Therapeutics, 1976

View PDFchevron_right

Effect of phenytoin on meperidine clearance and normeperidine formation

Susan Pond

Clinical Pharmacology and Therapeutics, 1981

View PDFchevron_right

Effect of a delayed-action phenytoin preparation on blood phenytoin concentration

Mervyn Eadie

Journal of Neurology, Neurosurgery, and Psychiatry, 1972

View PDFchevron_right

Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo

Wichittra Tassaneeyakul

British Journal of Clinical Pharmacology, 2003

View PDFchevron_right

Clinical application of the Mullen and Foster method for individualizing phenytoin dosage

Andrea Messori

The Italian Journal of Neurological Sciences, 1984

View PDFchevron_right

Effects of etoricoxib on the pharmacokinetics of phenytoin

Sumedh Gaikwad

2008

View PDFchevron_right

Different Phenytoin Oral Administration Regimens Could Modify Its Chronic Exposure and Its Saliva/Plasma Concentration

Pietro Fagiolino

View PDFchevron_right

Differential Kinetics of Phenytoin in Elderly Patients

Robert Belloto

Drugs & Aging, 1999

View PDFchevron_right

Phenytoin: A Guide to Therapeutic Drug Monitoring

sertini mrp

View PDFchevron_right

Critical appraisal of serum phenytoin variation with patient characteristics in a North Indian population

Suman Kushwaha

Neurology India, 2015

View PDFchevron_right

A Novel HPLC Method for Determination of Phenytoin in Human Plasma

Mariana Babayeva

Journal of Pharmaceutical Research International

View PDFchevron_right

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function

Kenneth Moore

Journal of clinical pharmacology, 2014

View PDFchevron_right

Severe phenytoin intoxication in a subject homozygous forCYP2C93

Renato Brandolese

Clinical Pharmacology & Therapeutics, 2001

View PDFchevron_right

Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parameters

Jorge Enrique Palomino Trujillo

The American Journal of Emergency Medicine, 1996

View PDFchevron_right

Bioavailability Studies of Drugs with Nonlinear Pharmacokinetics: II. Absolute Bioavailability of Intravenous Phenytoin Prodrug at Therapeutic Phenytoin Serum Concentrations Determined by Double-Stable Isotope Technique

Hamid Davoudi

The Journal of Clinical Pharmacology, 1993

View PDFchevron_right

Do total concentrations of phenytoin predict free concentrations in Malaysian pediatric patients?

Omer allela

View PDFchevron_right

Accuracy of Two Equations in Determining Normalized Phenytoin Concentrations

Laurie Mauro

DICP, 1989

View PDFchevron_right

Pharmacokinetic interaction between theophylline and erythromycin

Atholl Johnston

British Journal of Clinical Pharmacology, 1982

View PDFchevron_right

Pharmacokinetic Interactions between Concomitantly Administered Phenytoin with Rivaroxaban

S.N. Sriharsha

International Journal of Pharmaceutical Sciences and Drug Research, 2018

View PDFchevron_right

Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats

KG sathish kg

European Journal of Pharmaceutical Sciences, 2011

View PDFchevron_right

Benefits of a clinical pharmacokinetic service in optimising phenytoin use in the western Cape

Peter Folb, Praneet Valodia

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1998

View PDFchevron_right

Simplified quantitative determination of plasma phenytoin: on-line pre-column high-performance liquid immunoaffinity chromatography with sample pre-purification

Benny Johansson

Journal of chromatography, 1986

View PDFchevron_right

PHARMACOKINETIC STUDY OF PHENYTOIN IN MALAYSIAN PEDIATRIC PATIENTS AT PENANG HOSPITAL

Omer allela

View PDFchevron_right

Therapeutic drug monitoring of phenytoin needs vigilance: An individualized PD response is variable

IJRPP Journal

View PDFchevron_right

Altered Pharmacokinetics of Proguanil by Cuncurrent Administration of Phenytoin in Healthy Volunteers.

Prof. Julius O Soyinka

View PDFchevron_right